Noteworthy
DCC Radiation Oncology will deliver 11 oral and poster presentations at annual American Association of Physicists in Medicine conference.
Charles Thomas, MD, shares clinical trials insight as a featured guest on Johns Hopkins’ Seminars in Radiation Oncology podcast.
New London Hospital’s “Hospital Days” fundraiser will support new biopsy technology for advanced prevention and detection of breast cancer.
WCAX highlights Jamie Karch, MD, recognized by the National Council on Skin Cancer Prevention for her efforts and action in NH and VT.
Radiation Oncology Chair Charles R. Thomas Jr., MD, served on the steering committee for the newly released AACR Cancer Disparities Progress Report 2024.
New Dartmouth study uses an interdisciplinary approach to improve serious illness conversations between providers and patients with advanced cancer.
![Andrea Melville and Caroline Tavelli-Abar](/sites/default/files/styles/max_width_648/public/2024-07/DCC-Art-Patient-065_sized.jpg?itok=cF7XruN6)
The Gallery of Light: Andrea and Caroline’s Story of Art in Healing
The paths of two breast cancer journeys intersect at a shared experience and love of art. The result is an enduring friendship.
Noteworthy
DCC Radiation Oncology will deliver 11 oral and poster presentations at annual American Association of Physicists in Medicine conference.
Charles Thomas, MD, shares clinical trials insight as a featured guest on Johns Hopkins’ Seminars in Radiation Oncology podcast.
New London Hospital’s “Hospital Days” fundraiser will support new biopsy technology for advanced prevention and detection of breast cancer.
WCAX highlights Jamie Karch, MD, recognized by the National Council on Skin Cancer Prevention for her efforts and action in NH and VT.
Radiation Oncology Chair Charles R. Thomas Jr., MD, served on the steering committee for the newly released AACR Cancer Disparities Progress Report 2024.
New Dartmouth study uses an interdisciplinary approach to improve serious illness conversations between providers and patients with advanced cancer.
Experience the Dartmouth Cancer Center difference
Award-winning patient experience
Our patients rank us in the top 5% of healthcare organizations nationwide, earning us the Press Ganey Human Experience Pinnacle of Excellence Award 4 years in a row.
Highest NCI designation
Patient outcomes can improve by up to 25% when treated at an NCI-designated comprehensive cancer center.
Coordinated care
At Dartmouth Cancer Center, we don't treat a disease, we treat a person—a whole person. Our care team makes it easy to coordinate care, beyond just cancer treatment.
Clinical trials impact the future of healthcare
Clinical trials give cancer researchers information they need to discover new ways to prevent, find, and treat cancer. Many options available today would not be possible without clinical trials. Today's trials will build upon what we know to help future generations. Research like this depends upon all kinds of people taking part.
To find clinical trials at Dartmouth Cancer Center that are open and enrolling people, please visit Find a Clinical Trial or talk with your provider to discuss your options.
As one of 56 National Cancer Institute-designated Comprehensive Cancer Centers in the United States, and one of three in New England, our clinicians and scientists are working daily to bring their innovations directly to patients while delivering cutting-edge cancer treatments.